跳至主要内容
临床试验/NCT02191527
NCT02191527已完成不适用

Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services and Their Impact on Mother and Child Health Outcomes in Cabo Delgado Province, Mozambique

Elizabeth Glaser Pediatric AIDS Foundation0 个研究点目标入组 1,673 人开始时间: 2013年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,673
主要终点
The proportion of HIV positive pregnant women initiating antiretroviral therapy among eligible women.

研究概览

简要总结

The general goal of the proposed study is to evaluate the cost-effectiveness of POC technologies for diagnosis of syphilis, quantitative analysis for hemoglobin and CD4 counting performed within MCH services to improve maternal and infant health.

A prospective, quasi-experimental study will be done in Cabo Delgado province, where health facilities will be randomized in an intervention or comparison arm. Outcomes on maternal and infant health will be measured.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •First antenatal care visit
  • •Able to provide informed consent and signed consent form
  • •Minimum 18 years of age
  • •Diagnosed HIV positive at antenatal care visit
  • •Living in the catchment area of the health facility

排除标准

  • •Age <18 years
  • •No consent form signed
  • •Being on ART at time of first antenatal care visit

研究组 & 干预措施

Point of Care Testing

Experimental

The point-of-care devices will be located in the MCH services, where a trained lay counselor will do the tests.

干预措施: PIMA® for quantitative analysis of CD4-count (Device)

Point of Care Testing

Experimental

The point-of-care devices will be located in the MCH services, where a trained lay counselor will do the tests.

干预措施: Hemocue® (HemoCue AB, Angelhom, Sweden) for quantitative analysis of hemoglobin (Device)

Point of Care Testing

Experimental

The point-of-care devices will be located in the MCH services, where a trained lay counselor will do the tests.

干预措施: SD Bioline® (Standard Diagnostics Inc., South-Korea) for qualitative analysis of syphilis (Device)

Laboratory Testing - Standard of care

No Intervention

Samples sent to the laboratory for analysis, (standard of care)

结局指标

主要结局

The proportion of HIV positive pregnant women initiating antiretroviral therapy among eligible women.

时间窗: Within 1 month

Number of HIV positive pregnant women initiating antiretroviral therapy divided by the number of eligible HIV positive pregnant women

次要结局

  • The proportion of pregnant women tested and treated for anemia(Within 1 month)
  • Number of HIV infections in infants averted(1-3 months of age)
  • Proportion of women at first ANC visit tested and treated for syphilis(Within 1 month)

研究者

申办方类型
Other
责任方
Sponsor

相似试验